GlassScriptPhysician profile
Wade T Massey
NPI 1447818893
$3,213.01
in general payments reported to CMS, 2019-2025
18 companies · $1,378 in 2025
The $1,378 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $19.87 · 2021: $89.31 · 2022: $809 · 2023: $242 · 2024: $675 · 2025: $1,378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,233 · Entertainment: $61.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,233.41 |
| Entertainment | $61.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $999.86 | 2021-2025 | Gel-One Cross-Linked Hyaluronate, Visco-3 Sodium Hyaluronate |
| Stryker Corporation | $737.71 | 2025 | Actishield, Infinity Adaptis, Inbone |
| Depuy Synthes Sales INC. | $254.95 | 2024-2025 | Na, Healix Knotless Peek |
| Medline Industries LP | $162.37 | 2025 | |
| Novastep INC. | $149.64 | 2024 | Nexis |
| Vericel Corporation | $143.26 | 2023 | Maci |
| Medshape, INC. | $135.31 | 2025 | Dynanail |
| Prime Surgical, LLC | $129.71 | 2024 | |
| Theramicro, INC. | $111.56 | 2025 | Tekbrace Solo |
| Biocomposites INC | $65.81 | 2023 | Stimulan |
| Medical Device Business Services, INC. | $63.94 | 2025 | Dynacord |
| Heraeus Medical, LLC. | $63.10 | 2022-2024 | |
| Next Science LLC | $61.70 | 2024 | Surgx, Xperience, Blastx |
| Bioventus LLC | $35.85 | 2022-2024 | Bonescalpel & Sonicone (O.R.) |
| Si-Bone, INC. | $33.13 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| P Bar Medical LLC | $22.95 | 2025 | |
| Illuminoss Medical, INC. | $22.29 | 2021 | |
| Pacira Therapeutics, INC. | $19.87 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wade Massey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.